{"id":"https://openalex.org/W2052230544","doi":"https://doi.org/10.2133/dmpk.23.95","title":"No Effect of Imidafenacin, a Novel Antimuscarinic Drug, on Digoxin Pharmacokinetics in Healthy Subjects","display_name":"No Effect of Imidafenacin, a Novel Antimuscarinic Drug, on Digoxin Pharmacokinetics in Healthy Subjects","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2052230544","doi":"https://doi.org/10.2133/dmpk.23.95","mag":"2052230544","pmid":"https://pubmed.ncbi.nlm.nih.gov/18445988"},"language":"en","primary_location":{"id":"doi:10.2133/dmpk.23.95","doi":"https://doi.org/10.2133/dmpk.23.95","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.23.95","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086497338","display_name":"Susumu Nakade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu Nakade","raw_affiliation_strings":["Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Ibaraki, Japan. s.nakade@ono.co.jp","Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Ibaraki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Ibaraki, Japan. s.nakade@ono.co.jp","institution_ids":["https://openalex.org/I4210112155"]},{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Ibaraki, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tomoya Ohno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoya Ohno","raw_affiliation_strings":["Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035937915","display_name":"Kazuki Nakayama","orcid":"https://orcid.org/0000-0002-0254-2191","observed_orcids":["https://orcid.org/0000-0002-0254-2191"]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuki Nakayama","raw_affiliation_strings":["Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072844242","display_name":"Junsaku Kitagawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junsaku Kitagawa","raw_affiliation_strings":["Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059256259","display_name":"Yoshitaka Hashimoto","orcid":"https://orcid.org/0000-0002-8794-0550","observed_orcids":["https://orcid.org/0000-0002-8794-0550"]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshitaka Hashimoto","raw_affiliation_strings":["Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014364578","display_name":"Akihiro Ohnishi","orcid":"https://orcid.org/0000-0002-4295-3649","observed_orcids":["https://orcid.org/0000-0002-4295-3649"]},"institutions":[{"id":"https://openalex.org/I115498069","display_name":"Jikei University School of Medicine","ror":"https://ror.org/039ygjf22","country_code":"JP","type":"education","lineage":["https://openalex.org/I115498069"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihiro Ohnishi","raw_affiliation_strings":["Department of Laboratory Medicine, Daisan Hospital, Jikei University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Daisan Hospital, Jikei University School of Medicine","institution_ids":["https://openalex.org/I115498069"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012327150","display_name":"Yasuyuki Miyata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuyuki Miyata","raw_affiliation_strings":["Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210112155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3580,"currency":"USD","value_usd":3580},"apc_paid":null,"fwci":0.9107,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.77425249,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"23","issue":"2","first_page":"95","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.02250000089406967,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imidafenacin","display_name":"imidafenacin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.996999979019165},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8059999942779541},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.8100000023841858},{"id":"https://openalex.org/keywords/anticholinergic-drugs","display_name":"anticholinergic agents","score":0.8330000042915344},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9279999732971191},{"id":"https://openalex.org/keywords/co-administration","display_name":"co-administration","score":0.7149999737739563},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.6340000033378601},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.9679999947547913},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.9522373676300049},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8562523722648621},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7206138968467712},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6316018104553223},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5366823673248291},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.516119122505188},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.45850899815559387},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.43854495882987976},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41111159324645996},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3536572754383087},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.15488150715827942},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.047269195318222046},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2133/dmpk.23.95","doi":"https://doi.org/10.2133/dmpk.23.95","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.23.95","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:18445988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18445988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and pharmacokinetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W208036287","https://openalex.org/W281674839","https://openalex.org/W1968860914","https://openalex.org/W1985564638","https://openalex.org/W1997800712","https://openalex.org/W2015481396","https://openalex.org/W2019362433","https://openalex.org/W2029451638","https://openalex.org/W2079272387","https://openalex.org/W2094970779","https://openalex.org/W2098288167","https://openalex.org/W2131173377","https://openalex.org/W2145895010","https://openalex.org/W2155381616"],"related_works":["https://openalex.org/W2049834792","https://openalex.org/W2008576456","https://openalex.org/W1976367840","https://openalex.org/W1964032147","https://openalex.org/W2020021497","https://openalex.org/W2138945525","https://openalex.org/W1997931764","https://openalex.org/W2051750147","https://openalex.org/W2029910428","https://openalex.org/W2155429916"],"abstract_inverted_index":{"Plasma":[0],"digoxin":[1,43,67,76,91,116,136,160,184],"concentrations":[2],"are":[3],"increased":[4],"by":[5,188],"the":[6,22,31,40,174],"coadministration":[7],"of":[8,24,33,37,42,66,108,157,176,183,191],"anticholinergic":[9,28],"drugs,":[10],"such":[11],"as":[12],"propantheline,":[13],"which":[14],"decrease":[15],"gastrointestinal":[16],"motility.":[17],"The":[18,35,126,154,180],"present":[19],"study":[20],"evaluated":[21],"effect":[23,36],"imidafenacin,":[25],"a":[26,53,62,87,99],"novel":[27],"drug,":[29],"on":[30,39,70,79],"pharmacokinetics":[32,41,182],"digoxin.":[34],"imidafenacin":[38,109,192],"was":[44,92,112],"examined":[45],"in":[46,52,98,121,193],"14":[47],"healthy":[48,194],"Japanese":[49],"male":[50],"subjects":[51],"single-centre,":[54],"open-label,":[55],"randomized,":[56],"two-way":[57],"crossover":[58],"study.":[59],"Subjects":[60],"received":[61],"daily":[63,106],"oral":[64],"dose":[65,107],"0.25":[68],"mg":[69,78,111],"days":[71,80,97,119],"1":[72,123],"and":[73,75,138,149,166],"2":[74],"0.125":[77],"3":[81],"to":[82,178],"8":[83,96,118],"(period":[84,102],"1).":[85],"Following":[86],"2-week":[88],"washout":[89],"period,":[90],"administered":[93,114],"orally":[94],"for":[95,117,135,159],"similar":[100],"manner":[101],"2).":[103],"A":[104],"twice":[105],"0.1":[110],"concomitantly":[113],"with":[115],"either":[120],"period":[122],"or":[124],"2.":[125],"geometric":[127],"mean":[128],"ratios":[129],"[GMR]":[130],"(90%":[131],"confidence":[132],"intervals":[133],"[CIs])":[134],"C(max)":[137],"AUC(0-24)":[139],"(with/without":[140],"imidafenacin)":[141],"at":[142,169],"steady":[143,170],"state":[144,171],"were":[145],"0.88":[146],"(0.74,":[147],"1.04)":[148],"1.00":[150],"(0.90,":[151],"1.10),":[152],"respectively.":[153],"90%":[155],"CIs":[156],"GMR":[158],"trough":[161],"concentration,":[162],"urinary":[163],"excretion":[164],"amount":[165],"renal":[167],"clearance":[168],"fell":[172],"within":[173],"range":[175],"0.8":[177],"1.25.":[179],"steady-state":[181],"is":[185],"not":[186],"affected":[187],"concomitant":[189],"administration":[190],"subjects.":[195]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}